Covid-19 vaccine trials start in SA; Aspen can cope with Covid-19 wonder drug demand; SAA; CR infrastructure spend

Loading player...
In today's news headlines:
* The first clinical trial in South Africa and on the continent for a Covid-19 vaccine begins this week. The vaccine is already being evaluated in a large clinical trial in the UK where more than 4,000 participants have already been enrolled;
* South African pharmaceutical maker Aspen could provide 10 million dexamethasone tablets within a month, CEO Stephen Saad;
* South Africa’s unemployment rate rose to a 17-year high in the first quarter, even before the full impact was felt of the Covid-19 lockdown;
* President Cyril Ramaphosa says the government will galvanise R2.3bn in infrastructure investment to create about 1.8m jobs over the next decade; and
* The South African government said on Tuesday it had received unsolicited proposals from private sector funders, private equity investors and potential partners for a new national airline based on SAA. Learn more about your ad choices. Visit megaphone.fm/adchoices
23 Jun 2020 3PM English South Africa Investing · Business News

Other recent episodes

BNC#8 - Restoring power to the people: A call for electoral reform and accountable leadership

This compelling address explores leadership, democracy, and the urgent need for electoral reform in South Africa. Drawing on personal experiences in government and constitutional development, the speaker highlights the growing disconnect between citizens and political representatives. Through powerful stories and reflections, he advocates for a system that empowers individuals to…
29 Mar 8AM 25 min

The NdB Sunday Show: Willem Els - Why terror groups love South Africa

On today’s NdB Sunday Show, Chris Steyn talks to Willem Els, a consultant at the Transnational Threats and Organised Crime and the Justice and Violence Prevention Programme at the Institute for Security Studies (ISS) about why South Africa is considered to be so attractive to terror networks. Els describes how…
29 Mar 5AM 15 min